The Supreme Court Case That Will Determine the Future of Gene Patenting

The Supreme Court Case That Will Determine The Future Of Gene Patenting

Filed under: Drug Rehab Centers District of Columbia

Back in August, the D.C. Federal Circuit Court of Appeals ruled by a 2-1 margin that Myriad could patent the detection of two genes, BRCA1 and BRCA2, that have been linked to a heightened chance of breast and ovarian cancer in women. While Myriad and …
Read more on ThinkProgress

Endo Pharma Sues FDA To Protect Consumers From Non-Tamper Resistant …

Filed under: Drug Rehab Centers District of Columbia

Endo Health Solutions Inc. (ENDP: Quote) announced Friday that its subsidiary, Endo Pharmaceuticals Inc., has filed suit against the U.S. Food and Drug Administration or FDA seeking a formal determination whether the original formulation of OPANA ER …
Read more on RTT News

Klobuchar, Franken, Congressional Medical Technology Caucus announce new …

Filed under: Drug Rehab Centers District of Columbia

Washington, D.C. – The Congressional Medical Technology Caucus, co-chaired by U.S. Sen. … Franken, Food and Drug Administration (FDA) Commissioner Margaret Hamburg, Center for Devices and Radiological Health (CDRH) Director Jeff Shuren, LifeScience …
Read more on Coon Rapids ECM Publishers